AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Innontubilin 80mg Injection

Prescription Icon
Prescription Required

Marketer

BDR Pharmaceuticals Internationals Pvt

Salt Composition

Docetaxel (80mg)

Overview Innontubilin 80mg Injection

Tubulinan 80mg injection is a chemotherapy agent indicated for treating breast, non-small cell lung, prostate, and head and neck cancers. Administration is solely via intravenous injection by a healthcare professional. Dosage and frequency are determined individually by your physician based on your specific cancer and may adjust over time. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include shortness of breath, constipation, swelling, infections, appetite loss, myalgia, nail abnormalities, pain, and fatigue. Your doctor might prescribe additional medications to mitigate these. Report any unusual bruising, bleeding, sore throat, mouth sores, or fever immediately. This medication can suppress blood cell counts (red and white), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are mandatory. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, including antibiotics, to your doctor. Interactions with other drugs are possible. This medication is contraindicated during pregnancy and lactation. Both partners should employ reliable contraception throughout the treatment period to prevent conception.

Primary Ingredients of Innontubilin 80mg Injection

Not applicable. The original text "undefined" provides no meaning or intent to rephrase.

Uses of Innontubilin 80mg Injection

Cancers of the breast, lung (non-small cell), prostate, and head and neck.

Major Benefits of Innontubilin 80mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Innontubilin 80mg Injection:

  • Breathlessness
  • Constipation
  • Edema (swelling)
  • Infection
  • Loss of appetite
  • Muscle pain
  • Nail disorder
  • Pain
  • Weakness

How to use Innontubilin 80mg Injection:

This medication will be administered by your physician or registered nurse. Self-medication is strictly prohibited.

How Innontubilin 80mg Injection works:

Microtubule function is disrupted by the anticancer agent Innontubilin 80mg Injection, halting cancer cell division and proliferation. This ultimately leads to cancer cell death through growth inhibition.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Innontubilin 80mg Injection with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Innontubilin 80mg Injection to pregnant individuals poses a confirmed risk to the fetus. Therefore, its use during pregnancy is contraindicated. In exceptional, life-threatening circumstances, a physician might consider prescribing it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Administering Innontubilin 80mg Injection to breastfeeding individuals is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Innontubilin 80mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The 80mg Innontubilin injection poses no safety concerns for patients with renal impairment; no dosage alteration is necessary.

LiverLiverCAUTION

Patients with hepatic impairment should use Innontubilin 80mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Innontubilin 80mg Injection :

NA

Facts to Know About Innontubilin 80mg Injection

LabelValue
Type of Compound Taxane-based medications
Potential for Dependence None.
Type of Medication Cancer-fighting drugs
Mechanism of Action Microtubule-disrupting drugs: Taxane class

FAQs on Innontubilin 80mg Injection

Weight gain is a potential side effect of Innontubilin 80mg Injection. This can result from fluid retention, often manifesting as initial foot swelling before potentially affecting the entire body. Contact your physician promptly if you experience foot swelling.
Maintain your Innontubilin 80mg Injection regimen according to your physician's instructions. Treatment length depends on your specific cancer and your individual reaction to the therapy. Infusions are typically administered every three weeks.
Innontubilin 80mg Injection includes alcohol as an ingredient. Consequently, you might experience drowsiness, dizziness, confusion, or a feeling of intoxication. This could negatively impact your ability to operate vehicles or machinery immediately following administration. Therefore, abstain from alcohol while undergoing treatment with Innontubilin 80mg Injection to minimize potential adverse effects.
The injectable medication Innontubilin, at a dosage of 80mg, finds frequent application in the treatment of breast cancer, specific lung cancers, prostate cancer, stomach cancer, and cancers of the head and neck. Its mechanism of action involves inhibiting cellular growth and proliferation.
Innontubilin 80mg Injection is administered intravenously as a liquid solution by healthcare professionals in a clinical setting. The typical dosage regimen involves a single infusion over sixty minutes, repeated every three weeks.
Regular blood tests, including a complete blood count and liver function assessment, are required before each administration of your 80mg Innontubilin injection. These tests monitor blood cell levels and liver health to ensure suitability for treatment. Low white blood cell counts can lead to fever or infections.
Alopecia is a frequently observed adverse reaction associated with Innontubilin 80mg Injection. Hair regrowth typically occurs following discontinuation of Innontubilin 80mg Injection. Nevertheless, irreversible hair loss can occur in certain instances. Seek medical advice if you experience any hair loss concerns.
Administering Innontubilin 80mg Injection may result in edema (swelling affecting the extremities) and serious allergic responses. Prophylactic corticosteroids (dexamethasone) are provided to all patients for three days, commencing the day before Innontubilin 80mg Injection is given, to mitigate these risks. For patients with metastatic castration-resistant prostate cancer, the recommended protocol involves oral dexamethasone at 12, 3, and 1 hour before Innontubilin 80mg Injection infusion.
The taxoid-class anticancer medication, Innontubilin 80mg Injection, inhibits the proliferation and metastasis of malignant cells.
Innontubilin 80mg Injecti...
5,025
MRP 5,830
13% off